Skip to main content

Table 5 Multivariate analysis of clinical features and ERβ1 expression with overall survival

From: Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Feature (reference)

HR [CI 95%]

p value

ERβ1 > 40% (vs. ERβ1 < 40%)

1.16 [0.57–2.35]

0.681

Agea

1.03 [1.01–1.06]

0.0108*

Stage IIA

1.65 [0.81–6.97]

0.291

Stage IIB

2.39 [1.59–5.45]

0.112

Stage III/IV

3.01 [1.06–8.75]

0.0382*

Chemotherapy yes (vs. no)

0.56 [0.25–1.24]

0.1498

  1. Footnote: aContinuous (years). * P<0.05
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us